Additionally, there is a 63% risk of developing a second primary contralateral breast cancer within 25 years of the initial diagnosis for carriers affected with BRCA variants, with BRCA1 carriers having the highest risk [17]. This evidence concerns the gene BRCA1 and breast carcinoma.